v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOW FROM OPERATING ACTIVITIES:    
Net loss $ (7,157,946) $ (4,300,692)
Adjustments to reconcile net loss to cash used for operating activities:    
Depreciation 84,458 93,026
Amortization of intangible assets and write-off 267,273 304,983
Interest payable on Note 58,282 164,589
Loss on foreign currency 0 13,004
Reserve for inventory (513,400) (213,005)
Allowance for credit losses (250,000) (372,532)
Amortization of debt discount 261,833 124,000
Amortization of capitalized contract costs 173,062 175,900
Impairment of investment 2,500,000 0
Share based and warrant compensation for employees and consultants 146,571 225,245
Stock based fees to directors 20,004 18,006
Bad debt expense 15,000 100,000
Deferred income tax benefit 16,500 (22,998)
Amortization of operating lease right-of-use assets 25,419 79,521
Change in operating assets and liabilities:    
Accounts receivable (252,593) 855,829
Due from factor 74,170 25,150
Capitalized contract costs (75,227) (355,520)
Deposits 0 (7,976)
Right of use asset 0 (115,988)
Inventory 520,828 280,438
Prepaid expenses and other 27,325 85,523
Accounts payable (310,629) (502,987)
Income tax payable 0 15,000
Accrued liabilities 55,198 (42,116)
Deferred revenue (334,407) 526,240
Operating lease liabilities (20,410) (66,712)
Net cash used for operating activities (4,668,689) (2,914,072)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (12,012) (13,047)
Net cash used for investing activities (12,012) (13,047)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the exercise of warrants 6,966,558 1,908,099
Costs incurred for issuance of common stock (462,994) (172,350)
Proceeds from issuance of note payable 1,000,000 2,000,000
Repayment of note payable (455,000) (762,611)
Repayment of government loan (146,393) (150,024)
Proceeds from Employee Stock Purchase Plan 10,076 3,740
Net cash (used in) provided by financing activities 6,912,247 2,826,854
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 2,257,059 (73,796)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 437,604 511,400
CASH AND CASH EQUIVALENTS, END OF YEAR 2,694,663 437,604
Effect of exchange rate changes 25,513 26,469
Cash paid during the year for:    
Interest 60,793 175,755
Noncash investing and financing activities:    
Operating lease right-of-use asset and liability for new lease 0 79,521
Issuance of common stock for repayment of debt $ 1,786,991 $ 0